Speaker Profile

___	__
	Biography Sharon has been an Advanced Practice Nurse in high risk Obs & Gyn at Hamilton Health Sciences and is an Associate Clinical Professor in the Dept of Obs & Gyn at McMaster University. She holds a BScN from McMaster University, Masters in Education from Brock University and Masters and PhD in Nursing from Wayne State University (Detroit). Sharon is an member Ontario Maternal and Perinatal Death Review Committee (coroner’s committee), National Fetal Health Surveillance steering committee, and Canadian Association of Perinatal and Women’s Health Nurses (CAPWHN) including as President. She has served on multiple SOGC committees including ALARM, Obstetrical Content review, Guideline Oversite, Morbidity and Mortality and Conference Planning. She is an ALARM and FHS instructor. Disclosure 1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Sharon has been an Advanced Practice Nurse in high risk Obs & Gyn at Hamilton Health Sciences and is an Associate Clinical Professor in the Dept of Obs & Gyn at McMaster University. She holds a BScN from McMaster University, Masters in Education from Brock University and Masters and PhD in Nursing from Wayne State University (Detroit). Sharon is an member Ontario Maternal and Perinatal Death Review Committee (coroner’s committee), National Fetal Health Surveillance steering committee, and Canadian Association of Perinatal and Women’s Health Nurses (CAPWHN) including as President. She has served on multiple SOGC committees including ALARM, Obstetrical Content review, Guideline Oversite, Morbidity and Mortality and Conference Planning. She is an ALARM and FHS instructor.
Disclosure
1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).